Some patients have asked about payment plans or financing
This case underscores the importance of considering medication-induced colitis in patients presenting with persistent gastrointestinal symptoms, particularly in the absence of typical risk factors

Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial (September 2017) Doi: Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (May 2010) Doi: The Influence of Depressive Symptoms on Executive Functioning in Binge Eating Disorder: A Comparison of Patients and Non-Obese Healthy Controls (April 2019) Doi: Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review (August 05, 2021) Doi: SSRI Antidepressant Medications: Adverse Effects and Tolerability (February 01, 2001) Doi: Treatment of Obese Patients With Binge Eating Disorder Using Topiramate: A Review (July 07, 2009) Doi: Successful Treatment of Binge Eating Disorder With the GLP-1 Agonist Semaglutide: A Retrospective Cohort Study (August 08, 2023) Doi:
25 once daily)
For patients: Retatrutide is not currently available on the NHS or through private prescription in the UK Products sold online claiming to be retatrutide are unlicensed and potentially dangerous the MHRA advises against purchasing medicines from unregulated sources If you are interested in participating in a clinical trial, speak to your GP or specialist, who can advise on eligibility and refer you to appropriate research centres
That might look like embarrassment keeping someone from asking if GLP-1s are an option, shame over filling a prescription, or even misconceptions that prevent seeking support and treatment